EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Clinical Trials in Pharmaceutical Development: Trends and Challenges

Dr. Ayesha Khan

American Journal of Pharmaceutics · 2022-10-31 · 3 (5) · 13-21

DOI: 10.71465/ajph2175 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2022-10-31. Written by Dr. Ayesha Khan. The full text is freely available (open access, CC BY 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Clinical trials are pivotal in the pharmaceutical development process, serving as the bridge between laboratory research and clinical application. This article examines current trends and challenges in clinical trials, emphasizing the impact of technological advancements, regulatory complexities, and patient-centric approaches. The integration of artificial intelligence (AI), real-world data (RWD), and adaptive trial designs are reshaping trial methodologies. However, issues such as recruitment difficulties, ethical considerations, and high attrition rates persist. Addressing these challenges requires innovative strategies and collaborative efforts across the healthcare ecosystem.

Cite

APA

Khan, D. A. (2022). Clinical Trials in Pharmaceutical Development: Trends and Challenges. American Journal of Pharmaceutics, 3(5), 13-21. https://doi.org/10.71465/ajph2175

Vancouver

Khan DA. Clinical Trials in Pharmaceutical Development: Trends and Challenges. American Journal of Pharmaceutics. 2022;3(5):13-21. doi:10.71465/ajph2175

BibTeX
@article{Khan2022,
  author = {Khan, Dr. Ayesha},
  title = {Clinical Trials in Pharmaceutical Development: Trends and Challenges},
  journal = {American Journal of Pharmaceutics},
  year = {2022},
  volume = {3},
  number = {5},
  pages = {13--21},
  doi = {10.71465/ajph2175}
}
Start for free →